期刊文献+

S-100阳性树突状细胞在卵巢上皮癌组织中的分布及意义 被引量:5

Distribution and significance of S-100(+)DC in epithelial ovarian cancer tissue
暂未订购
导出
摘要 目的 :探讨S 10 0 ( +)树突状细胞 (dendriticcell,DC)在卵巢上皮癌组织中的分布及意义。方法 :用抗S 10 0蛋白抗体和免疫组织化学的方法检测人卵巢上皮癌患者肿瘤组织中DC的分布及数量。结果 :共检测 5 9例卵巢上皮肿瘤患者 ,肿瘤组织中见DC浸润 ,S 10 0 ( +)DC数与肿瘤临床分期(r =-0 3 10 ,P <0 0 1)和组织分级(r =-0 45 8,P <0 0 5 )呈负相关 ;S 10 0 ( +)DC数“大量组 (≥ 10 /HPF)”的 3、5年生存率 ( 5 8 3 %、41 7% )比“少量组 ( <10 /HPF)”( 3 1 4%、0 )明显提高 ;P <0 0 1。结论 OBJECTIVE:To investigate the distribution and significance of S-100(+)DC in epithelial ovarian cancer.METHODS:Immunohistochemical methods was engaged to measure the anti-S100 antibody positive cells infiltrated in epithelial ovarian cancer tissue.RESULTS:Fifty-nine cases of epithelial ovarian carcinoma were reviewed.S-100(+)DC were demonstrated among the malignant cells and/or around the tumor.The amount of S-100(+)DC had a negative relation to the clinical stage (r= -0.310,P<0.01) and histological grade of ovarian carcinoma (r=-0.458,P<0.05).Three or five year survival rate of patients with the 'many' S-100(+)DC (equal or more than 10 cells per 10 high-power fields) in the tumor (58.3%,41.7%) were higher than that of patients with the 'few'(DC less than 10 cells per 10 high-power fields,31.4%,0),P<0.01.CONCLUSION: DC plays an important role in anti-tumor immune of ovarian epithelial carcinoma host.
出处 《肿瘤防治杂志》 2004年第3期233-236,共4页 China Journal of Cancer Prevention and Treatment
基金 国家自然科学基金资助 ( 3 9970 770 )
关键词 树突细胞/免疫学 抗原提呈细胞 卵巢肿瘤/病理学 dendritic cell/immunology antigen-presenting cells ovarian neoplasms/pathology
  • 相关文献

参考文献11

  • 1曹泽毅.中华妇产科学[M].北京:人民卫生出版社,1999.2129.
  • 2Inoue K Furihata M, Ohtsukiy, et al. Distribution of S-100 pro tein-positive dendritic cells and expressin of HLA DR antigen in transitional cell carcinoma cf tumor progression and prognosis[J]. Virchoow Archh A Pathol A nat Histopathol, 1993,422(5):351-3
  • 3Takahashi K. Yamaguchi H,Ishizeki J,et al. Immunohisto chemical and immunoelectron microscopic localization of S-100 protein in the interdigitating reticulum cells of the human lymph node[J]. Virchows Arch,1981,37(2) :125-135.
  • 4Kakeji Y,Maehara Y,Korenaga D,et al. Prognostic significance of tumor-host interaction in clinical gastric cancer : relationship between DNA ploidy and dendritic cell infiltration[J]. J Surg Oncol, 1993,52(4) :207-212.
  • 5Steinman R M. The dendritic cell system and it is role in immu nogenecity[J]. Annu Rev Immunol,1991,9:271-296.
  • 6Tsuge T, Yamakawa M,Tsukamoto M. Infiltrating dentritic/Langerhans cells in primary cancer[J]. Breast Cancer Res Treat,2000,59(2): 141 152.
  • 7Nakano T,Oka K,Takahashi T,et al. Roles of Langerhang cells and T-lymphocytes infiltrating cancer tissues in patients treated by radiation therapy for cervical cancer[J]. Cancer, 1992,70(3):2839-2844.
  • 8Ameb K, Mori M. Enjoji M S-100 protein-posistive dendritic cells in colorectal adenocarcinomas [J]. Cancer, 1989, 63 (8):496- 503.
  • 9Imai Y, Yamakawa M. Dendritic cells in esophageal cancer and lymph node tissues[J]. In Vitro, 1993,7(3):239-248.
  • 10Ikeguchi M, Ikeda M, Tatebe S, et al. Clinical significance of dendritic cell infiltration esophageal squamous cell carcinoma[J]. OncolRep,1998,5(5): 1185- 1189.

二级参考文献1

共引文献3236

同被引文献40

  • 1周希亚,沈铿,何维.树突状细胞与卵巢癌细胞的融合及体外抗肿瘤作用的研究[J].现代妇产科进展,2004,13(6):426-429. 被引量:3
  • 2李琳,张震宇,王淑珍,刘崇东,翟妍,刘晋伟.脐血树突状细胞经卵巢癌细胞刺激后抗卵巢癌免疫应答的体外研究[J].北京医学,2006,28(8):452-454. 被引量:9
  • 3Ameb K,Mori M.Enjoji M S-100 protein-posistive dendritic cells in colorectal adenocarcinomas[J].Cancer,1989,63 (8):496 -503.
  • 4Imai Y,Yamakawa M.Dendritic cells in esophageal cancer and lymph node tissues[J].In Vitro,1993,7(3):239-248.
  • 5Jager E,Jager D,Knuth A.CTL-defined cancer vaccines:perspectives for active immunotherapeutic interventions in minimal residual disease[J].Cancer Metastasis Rev,1999,18(1):143 -150.
  • 6Hart D N,Hill G R.Dendritic cell immunotherapy for cancer:application to low-grade lymphoma and multiple myeloma[J].Immunol Cell Biol,1999,77(5):451-459.
  • 7Li J,Holmes L M,Franek K J,et al.Purified hybrid cells from dendritic cell and tumor cell fusions are superior activators of antitumor immunity[J].Cancer Immumol Immunother,2001,50(9):456-462.
  • 8Homma S,Toda G,Gong J,et al.Preventive antitumor activity against hepatocellular carcinoma (HCC) induced by immunization with fusions of dendritic cells and HCC cells in mice[J].J Gastroenterol,2001,36(11):764-771.
  • 9Engleman EG. Dendritic cell-based cancer immunotherapy. Sermin Oncol, 2003,30(Suppl 8) : 23-29.
  • 10Cai XY, Gao Q, Qiu SJ, et al. Dendritic cell infiltration and prognosis of human hepatocellular carcinoma. J Cancer Res Clin Oncol, 2006,19:1-9.

引证文献5

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部